Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026)

Alto Neuroscience (ANRO) reported Interest & Investment Income of $1.6 million for Q1 2026, down 14.56% on a YoY basis from $1.8 million in Q1 2025, and little changed sequentially from $1.6 million in Q4 2025.

Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026) Analysis & Trends

Alto Neuroscience (ANRO) has 4 years of Interest & Investment Income data on file, last reported at $1.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income fell 14.56% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (down 30.52% YoY), and the FY2025 full-year result was $6.6 million, down 25.4% from the prior year.
  • Interest & Investment Income was little changed at $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.7 million in Q2 2024 to a low of $230000.0 in Q1 2023.
  • A 4-year average of $1.5 million and a median of $1.6 million in 2025 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income jumped 577.39% in 2024 and tumbled 38.72% in 2025, its largest moves.
  • Tracing ANRO's Interest & Investment Income over 4 years: stood at $738000.0 in 2023, then surged by 189.3% to $2.1 million in 2024, then fell by 26.89% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
  • Business Quant data shows ANRO's Interest & Investment Income at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Alto Neuroscience 869.36 Mn 869.36 Mn - 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.68 Mn
Mar 31, 2025 1.83 Mn
Dec 31, 2024 2.14 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 2.66 Mn
Mar 31, 2024 1.56 Mn
Dec 31, 2023 738,000.00
Sep 30, 2023 714,000.00
Jun 30, 2023 667,000.00
Mar 31, 2023 230,000.00